Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.48 USD | -9.68% | -1.75% | +4.92% |
May. 08 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
Apr. 19 | US FDA mandates label updates on CAR-T cancer therapies | RE |
Financials (USD)
Sales 2024 * | 92.46M | Sales 2025 * | 123M | Capitalization | 255M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -22M | EV / Sales 2024 * | 2.76 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.07 x |
P/E ratio 2024 * |
-2.27
x | P/E ratio 2025 * |
-8.24
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.5% |
Latest transcript on 2seventy bio, Inc.
1 day | -9.68% | ||
1 week | -1.75% | ||
Current month | -1.75% | ||
1 month | -8.94% | ||
3 months | -19.86% | ||
6 months | +76.38% | ||
Current year | +4.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Susan Abu-Absi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Lynch
BRD | Director/Board Member | 65 | 21-10-14 |
Nick Leschly
CHM | Chairman | 51 | 21-05-03 |
Chip Baird
CEO | Chief Executive Officer | 52 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.23% | 2 M€ | -25.75% | ||
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.48 | -9.68% | 700,161 |
24-05-07 | 4.96 | +0.20% | 363,321 |
24-05-06 | 4.95 | +3.99% | 453,659 |
24-05-03 | 4.76 | -3.45% | 598,347 |
24-05-02 | 4.93 | +7.17% | 568,761 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.92% | 255M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- TSVT Stock